GALIMI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 3.221
EU - Europa 1.620
AS - Asia 1.579
SA - Sud America 142
AF - Africa 26
OC - Oceania 20
Totale 6.608
Nazione #
US - Stati Uniti d'America 3.153
CN - Cina 700
IT - Italia 571
SG - Singapore 410
DE - Germania 212
GB - Regno Unito 132
BR - Brasile 115
IE - Irlanda 114
JP - Giappone 94
FI - Finlandia 78
HK - Hong Kong 74
SE - Svezia 74
FR - Francia 73
VN - Vietnam 65
IN - India 64
AT - Austria 62
CA - Canada 52
KR - Corea 49
NL - Olanda 45
UA - Ucraina 44
PL - Polonia 43
ES - Italia 29
BE - Belgio 23
CH - Svizzera 23
RU - Federazione Russa 22
ID - Indonesia 20
TR - Turchia 19
AU - Australia 18
TW - Taiwan 17
EE - Estonia 16
MX - Messico 12
RO - Romania 12
AR - Argentina 11
IR - Iran 10
BD - Bangladesh 8
CZ - Repubblica Ceca 8
DK - Danimarca 8
NO - Norvegia 8
TH - Thailandia 8
IQ - Iraq 7
ZA - Sudafrica 7
CO - Colombia 6
GR - Grecia 5
UZ - Uzbekistan 5
EC - Ecuador 4
HU - Ungheria 4
CI - Costa d'Avorio 3
IL - Israele 3
KE - Kenya 3
LK - Sri Lanka 3
PE - Perù 3
PK - Pakistan 3
SI - Slovenia 3
BG - Bulgaria 2
CL - Cile 2
DM - Dominica 2
EG - Egitto 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
CG - Congo 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
IM - Isola di Man 1
MN - Mongolia 1
MY - Malesia 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
UG - Uganda 1
Totale 6.608
Città #
Ann Arbor 509
Chandler 283
Fairfield 261
Ashburn 247
Singapore 244
Beijing 187
Seattle 122
Woodbridge 117
Houston 104
Dublin 98
Wilmington 88
Cambridge 87
Shanghai 86
Torino 83
Turin 83
Boardman 68
Dallas 60
Milan 58
Santa Clara 54
Vienna 52
Pisa 48
Los Angeles 46
Dearborn 41
Hong Kong 41
Tokyo 38
Nyköping 36
New York 35
Redwood City 35
Munich 32
Warsaw 31
Jacksonville 29
Guangzhou 28
Naples 27
Princeton 26
The Dalles 25
Villeurbanne 24
Columbus 23
Helsinki 23
Manchester 22
Medford 22
Buffalo 21
Nanjing 21
London 20
Seoul 19
Brussels 18
San Diego 18
Pieve Emanuele 17
Jakarta 16
Ottawa 16
Taipei 16
Tallinn 16
Amsterdam 15
Changsha 15
Chicago 15
Lappeenranta 15
Boston 14
Fremont 14
Hangzhou 14
Wuhan 14
Frankfurt am Main 13
Ho Chi Minh City 13
Toronto 13
Chengdu 12
Genoa 12
Paris 12
Dong Ket 11
Nanchang 11
Nuremberg 11
Rome 11
Luni 10
Phoenix 10
Shenyang 10
Berlin 9
Chongqing 9
Hanoi 9
Hefei 9
Moscow 9
Barcelona 8
Fuzhou 8
Pittsburgh 8
Salt Lake City 8
São Paulo 8
Zurich 8
Austin 7
Bengaluru 7
Bethesda 7
Bologna 7
Duncan 7
Montreal 7
Zhengzhou 7
Atlanta 6
Central 6
Chennai 6
Düsseldorf 6
Eitensheim 6
Galway 6
Heidelberg 6
Kocaeli 6
Nashville 6
Shenzhen 6
Totale 4.188
Nome #
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 904
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 870
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 387
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 384
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 367
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. 337
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 331
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 319
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment 306
Only a subset of Met-activated pathways are required to sustain oncogene addiction 298
Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3. 297
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. 274
Inhibition of Src impairs the growth of met-addicted gastric tumors. 270
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 251
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 233
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer 188
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours 125
Met as a potential therapeutic target in basal-like breast cancer: An in vivo approach in a stem-cell perspective 121
Met as a potential therapeutic target in basal-like breast cancer 117
Identification and pre-clinical validation of surrogate soluble biomarkers correlating with therapeutic response to met inhibition 115
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients 106
Signaling response to transient redox stress in human isolated T cells: Molecular sensor role of syk kinase and functional involvement of IL2 receptor and L-selectine 106
Totale 6.706
Categoria #
all - tutte 15.763
article - articoli 0
book - libri 0
conference - conferenze 1.973
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021391 0 0 0 0 0 47 69 38 45 63 32 97
2021/20221.006 110 90 72 98 62 59 87 71 52 62 149 94
2022/2023736 73 77 31 78 52 149 41 64 70 16 44 41
2023/2024563 56 54 35 46 38 51 33 66 16 54 78 36
2024/2025974 26 35 98 71 145 95 43 73 105 78 94 111
2025/2026980 206 108 138 200 229 99 0 0 0 0 0 0
Totale 6.706